Gapping down
In reaction to disappointing earnings/guidance:
- SON -6.7%, HTHT -4.2% (Q2 update) SNBR -3%, ANGO -2.5%, MS -0.5%
Other news:
- TCDA -33.2% (provides regulatory update for veverimer; FDA has identified deficiencies)
- INMB -16.7% (stock offering)
- BCEL -12.6% (prices offering of 7,031,250 shares of its Class A Common Stock and 781,250 shares of its Class B Common Stock, each at a price to the public of $16.00 per share)
- APTO -11.5% (prices offering of 10.5 mln shares of common stock at $5.25 per share)
- NCLH -7.7% (commences underwritten public offering of $250 mln of ordinary shares; provides COVID-19 updates)
- PROF -7% (prices offering of of 2,758,621 common shares at $14.50 per share)
- ADPT -5.5% (prices offering of 8,000,000 shares of its common stock at $40.00 per share)
- AAL -4.9% (warns 25K employees of potential job cuts; also says June passenger revs down more than 80% yr/yr)
- TWTR -4% (falls on headlines of high profile Twitter account hacks)
- CYTK -3.3% (announces $150 mln common stock offering)
Analyst comments:
- GSX -5.8% (downgraded to Equal Weight from Overweight at Barclays)
- KBH -2.8% (downgraded to Sell from Neutral at Goldman)
- PTON -2.7% (downgraded to Neutral from Buy at UBS)
- DIS -2.4% (downgraded to Market Perform from Outperform at Cowen)
- CSCO -1.9% (downgraded to Neutral from Overweight at JP Morgan)